References
- Holstad M., Sandier S. Aminoguanidine, an inhibitor of nitric oxide formation, fails to protect against insulitis and hyperglycemia induced by multiple low dose streptozocin injections in mice. Autoimmunity 1993; 15: 311–314
- Kolb H., Kiesel U., Krönke K. D., Kolb-Bachofen V. Suppression of low dose streptozocin induced diabetes in mice by administration of nitric oxide synthase inhibitor. Life Sci. 1991; 49: 213–217
- Lukic M. L., Stosic-Grujicic S., Ostojic N., Chan W. L, Liew F. Y. Inhibition of nitric oxide generation affects the induction of diabetes by streptozocin in mice. Biochem. Biophys Res. Commun. 1991; 178: 913–920
- Papaccio G., Esposito V., Latronico M. V. G., Pisanti F. A. Administration of a nitric oxide synthase inhibitor does not suppress low-dose streptozocin-induced diabetes in mice. Int. J. Pancr. 1995, in press
- Corbett J. A., Mc Daniel M. L. Does nitric oxide mediate autoimmune destruction of B cells? Possible therapeutic interventions in IDDM. Diabetes 1992; 41: 897–903
- Eizirik D. L., Sandier S., Welsh N., Cetkovic-Cvrje M., Nieman A., Geller D. A., Pipeleers D. G., Bendtzen K., Hellerström C. Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. J. Clin. Invest. 1994; 93: 1968–1974
- Maclaren N., Lafferty K. The 12th International Immunology and Diabetes Workshop. Orlando, Florida. Diabetes 1993; 42: 1099–1104
- Pueyo M. E., Gonzalez W., Pussard E., Arnal J. F. Insulin secretion in rats with chronic nitric oxide synthase blockade. Diabetologia 1994; 37: 879–884